Safety Notices

From time to time notices relating to the safety, efficacy and quality of human medicinal products are published by the Health Products Regulatory Authority.

The issues covered by these notices include medicinal product safety information, updated efficacy information on the appropriate usage of medicines and quality defect information.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General information provided by 3rd parties as approved by the HPRA, e.g. MIMS, Direct Healthcare Professional Letter or Product Information Update

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
29/04/2020 Medicinal Product Shortages - update - 29 April 2020 Advisory
22/04/2020 Medicinal Product Shortages - update - 22 April 2020 Advisory
16/04/2020 Cyproterone acetate - Important Safety Information from Bayer Ltd as approved by the HPRA 3rd Party Publications
15/04/2020 Medicinal Product Shortages - update - 15 April 2020 Advisory
08/04/2020 Medicinal Product Shortages - update - 8 April 2020 Advisory
07/04/2020 HPRA IMF Article March 2020 3rd Party Publications
07/04/2020 HPRA MIMS Articles April 2020 3rd Party Publications
01/04/2020 Medicinal Product Shortages - update - 1 April 2020 Advisory
25/03/2020 Medicinal Product Shortages - update - 25 March 2020 Advisory
24/03/2020 Esmya 5mg Tablets (Ulipristal acetate) - Important Safety Information from Gedeon Richter UK Ltd as approved by the HPRA 3rd Party Publications